Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities
Net loss	$ (348,974)	$ (335,844)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash LNG inventory write-downs	216	17,502
Depreciation and amortization expense	24,089	17,769
Share-based compensation	16,171	16,140
Amortization of debt issuance costs and discount	12,817	9,116
Loss on early extinguishment of debt	1,457	88,992
Total losses on derivatives, net	182,169	126,183
Net cash used for settlement of derivative instruments	(8,817)	(37,262)
Impairment expense	10,166	176
Other	303	8,627
Changes in restricted cash for certain operating activities	43,366	75,233
Changes in operating assets and liabilities:
Accounts and interest receivable	1,092	(28,083)
Inventory	(1,531)	(29,676)
Accounts payable and accrued liabilities	(27,831)	73,002
Deferred revenue	(1,000)	(1,003)
Other, net	7,617	(15,052)
Net cash used in operating activities	(88,690)	(14,180)
Cash flows from investing activities
Property, plant and equipment, net	(1,149,827)	(590,998)
Use of restricted cash for the acquisition of property, plant and equipment	1,151,073	572,623
Other	(17,861)	(46,164)
Net cash used in investing activities	(16,615)	(64,539)
Cash flows from financing activities
Proceeds from issuances of debt	1,908,000	2,500,000
Repayments of debt	(415,000)	0
Debt issuance and deferred financing costs	(49,307)	(58,395)
Investment in restricted cash	(1,423,595)	(1,929,288)
Distributions and dividends to non-controlling interest	(20,098)	(20,050)
Proceeds from exercise of stock options	0	958
Payments related to tax withholdings for share-based compensation	(976)	(3,771)
Other	2	20
Net cash provided by (used in) financing activities	(974)	489,474
Net increase (decrease) in cash and cash equivalents	(106,279)	410,755
Cash and cash equivalents—beginning of period	1,201,112	1,747,583
Cash and cash equivalents—end of period	$ 1,094,833	$ 2,158,338